Pharmazz, Inc.
Pharmazz, Inc.
Explore linked clinical trials.8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3 Evaluation of Sovateltide for the Treatment of Acute Traumatic Brain Injury | Brain Injuries, Traumatic, Craniocerebral Trauma, brain disorder, brain injury, central nervous system disorder, injury, nervous system disorder, nervous system injury | Not yet recruiting | Phase 3 | 2026-10-06 | NCT07861126 | |
| Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke | Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic disease, nervous system disorder, stroke disorder, vascular disorder | Active, not recruiting | Phase 4 | 2026-09-29 | NCT05955326 | |
| A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients | Hemorrhage, Hypovolemia, Hypovolemic Shock, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock | Recruiting | Phase 4 | 2026-09-17 | NCT05956418 | |
| A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent | Hypovolemic Shock, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock | Not yet recruiting | Phase 3 | 2026-09-17 | NCT05251181 | |
| Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS | Hypoxia, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Signs and Symptoms, Respiratory, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder | Not yet recruiting | Phase 2 | 2026-09-17 | NCT05241067 | |
| Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-15 | NCT05691244 | |
| Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypoxia, Hypoxia, Brain, Infant, Newborn, Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, brain disorder, brain hypoxia - ischemia, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, perinatal asphyxia, vascular disorder | Recruiting | Phase 2 | 2025-12-31 | NCT05514340 | |
| PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury | Acute Spinal Cord Injury | Recruiting | Phase 2 | 2025-07-04 | NCT04054414 |